Related Experiment Video
Updated: Jan 19, 2026

Targeting Liver Tumors with Oncolytic Viruses via the Hepatic Artery
Targeting Hepatitis B Virus Covalently Closed Circular DNA and Hepatitis B Virus X Protein: Recent Advances and New
Nicholas A Prescott1,2, Yaron Bram3, Robert E Schwartz3,4
1Chemical Biology Program , Memorial Sloan Kettering Cancer Center , 1275 York Avenue , New York , New York 10065 , United States.
Abstract:
Chronic Hepatitis B virus (HBV) infection remains a worldwide concern and public health problem. Two key aspects of the HBV life cycle are essential for viral replication and thus the development of chronic infections: the establishment of the viral minichromosome, covalently closed circular (ccc) DNA, within the nucleus of infected hepatocytes and the expression of the regulatory Hepatitis B virus X protein (HBx). Interestingly, nuclear HBx redirects host epigenetic machinery to activate cccDNA transcription. In this Perspective, we provide an overview of recent advances in understanding the regulation of cccDNA and the mechanistic and functional roles of HBx. We also describe the progress toward targeting both cccDNA and HBx for therapeutic purposes. Finally, we outline standing questions in the field and propose complementary chemical biology approaches to address them.
Related Concept Videos
04:46Targeting Liver Tumors with Oncolytic Viruses via the Hepatic Artery
13:04A Protocol for Analyzing Hepatitis C Virus Replication
09:02Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
10:28A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
09:12Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

